For 3Q15e, Whitecap has reported average production of 41,800 boe/d, which is 5% better than our outlook and the Company’s prior guidance, from E&D capital spending of $51 mm which was 24% below our prior estimate for the period. Better than anticipated production levels were driven partially by stronger than anticipated production performance and operating efficiencies from the Company’s 3Q15 development program, particularly at its core Viking, Cardium and Elnora properties as well as two smal ....